ストックスクリーナーアプリを入手
147.08
1.48%
2.14
アフターアワーズ：
147.50
0.42
+0.29%
前日終値:
$144.94
開ける：
$144.16
24時間の取引高:
761.39K
Relative Volume:
0.99
時価総額：
$12.90B
収益：
$12.52B
当期純損益:
$859.62M
株価収益率:
29.24
EPS:
5.03
ネットキャッシュフロー:
$1.27B
1週間 パフォーマンス:
-7.09%
1か月 パフォーマンス:
-8.47%
6か月 パフォーマンス:
+9.39%
1年 パフォーマンス:
+85.12%
1日の値動き範囲:
$143.20
$147.49
1週間の範囲:
$138.00
$150.00
52週間の値動き範囲:
$78.05
$168.50
Davita Inc Stock (DVA) Company Profile
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
DaVita Inc. Reports Strong Q3 2024 Performance - MSN
DaVita's SWOT analysis: healthcare giant's stock faces regulatory shifts - Investing.com
DaVita's SWOT analysis: healthcare giant's stock faces regulatory shifts By Investing.com - Investing.com UK
DaVita Inc. (NYSE:DVA) Q3 2024 Earnings Call Transcript - MSN
DaVita Inc. (NYSE:DVA) Shares Sold by New York State Teachers Retirement System - MarketBeat
Raymond James & Associates Raises Stock Position in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up - MSN
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc. (NYSE:DVA) Receives $161.80 Consensus Target Price from Brokerages - MarketBeat
DaVita (DVA) Shares Plummet Following Disappointing Earnings Rep - GuruFocus.com
DaVita price target raised to $164 from $150 at Barclays - TipRanks
DaVita Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
International Assets Investment Management LLC Invests $10.35 Million in DaVita Inc. (NYSE:DVA) - MarketBeat
Why DaVita Stock Withered on Wednesday - MSN
Earnings call: DaVita maintains guidance despite headwinds and hurricanes - Investing.com India
Earnings call: DaVita maintains guidance despite headwinds and hurricanes By Investing.com - Investing.com Canada
DaVita (NYSE:DVA) Announces Earnings Results, Misses Expectations By $0.17 EPS - MarketBeat
DaVita is Now Oversold (DVA) - Nasdaq
Decoding DaVita Inc (DVA): A Strategic SWOT Insight - GuruFocus.com
DaVita (NYSE:DVA) Shares Gap Down Following Weak Earnings - MarketBeat
DaVita Inc. (NYSE:DVA) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
DaVita Inc (DVA) Q3 2024 Earnings Call Highlights: Strong Financial Performance Amid ... - Yahoo Finance
DaVita HealthCare: Q3 Earnings Snapshot - The Advocate
DaVita Inc (DVA) Q3 2024 Earnings: Revenue Beats at $3.264B, EPS Misses at $2.50 - GuruFocus.com
Hemodialysis Market to reach $111.8 billion by 2032 | DaVita - openPR
DaVita (DVA) Q3 2024 Earnings Call Transcript - Yahoo! Voices
Dialysis firm DaVita misses third-quarter profit estimates on higher costs - MSN
DaVita HealthCare (DVA) Q3 Earnings Miss Estimates - Yahoo Finance
DaVita shares tumble 17% on earnings miss By Investing.com - Investing.com South Africa
DaVita shares tumble 17% on earnings miss - Investing.com
DaVita reports Q3 adjusted EPS $2.59, consensus $2.73 - TipRanks
DaVita earnings missed by $0.13, revenue topped estimates - Investing.com Canada
DaVita Inc. 3rd Quarter 2024 Results - PR Newswire
Is DaVita (NYSE:DVA) A Risky Investment? - Simply Wall St
DaVita Inc. (NYSE:DVA) Short Interest Update - MarketBeat
DaVita Inc. stock rises Monday, still underperforms market - MarketWatch
DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program - Quantisnow
DaVita Health bus tour offers free health screenings - CW39 Houston
DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock? - MSN
Dumont & Blake Investment Advisors LLC Has $1.16 Million Stock Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally? - MSN
DaVita HealthCare (DVA) Stock Moves -0.23%: What You Should Know - Yahoo Finance
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 - PR Newswire
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
0.01%
大文字化:
|
ボリューム (24 時間):